The IQVIA team in the Middle East works to provide clarity in such a dynamic market. Our vast experience, local team of healthcare professionals, and global pool of resources, give us the knowledge and understanding to help clients navigate through the local cultural and regulatory nuances, and respond to new market realities quickly, effectively, and with more precision.
We help our clients predict future trends, minimize risks, and understand the local market better. Our information, analytics, technology solutions, and consulting expertise empower them with tools and real-world evidence that grant in-depth insights to make better informed decisions.
The Middle Eastern healthcare and pharmaceutical markets are in an ongoing state of innovative transformation. While spending has started to saturate the market, trends such as compulsory health insurance schemes and medical tourism push players across the ecosystem to reflexively adopt the latest advancements, connect with each other, and optimize existing resources.
Building S2B, Downtown Kattameya
Road 90, 5th Settlement
New Cairo, Egypt
QuintilesIMS, KIPCO Tower, 27th Floor
Block 9, Al Shuhadaa St, Sharq
P.O Box 25363
Sin El Fil, Beirut Hall Area
Next to Square Center
Getaway Center, 2nd floor
Ccc House Ramallah
Ersal Center, Ramallah
West Bank, Palestine
Convention Tower, 11th Floor
Al Saada Street
United Arab Emirates
+971 4 524 29 00
The Advent of Technology in Kenya’s Healthcare Sector
Rapid advancements in the world of technology provides a platform for the development of a strong and affordable healthcare system in developing economies like Kenya.
Osteoporosis in the Kingdom Of Saudi Arabia
Osteoporotic fractures frequently require inpatient care, and are associated with elevated risks of morbidity, mortality, and re-hospitalization, hence incur substantial hospital and indirect costs.
Oncology in the Middle East Market
The global oncology market is expected to continue growing at 9% between 2016 and 2021, one of the highest forecasted growth rates. The focus on oncology will remain high over the next decade as companies continue to invest resources and efforts.